| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | 8,683,132 | 8,779,507 |
| Net change in cash and cash equivalents | 174,499 | 2,897,528 |
| Cash and cash equivalents at beginning of period | 1,920,144 | - |
| Cash and cash equivalents at end of period | 2,094,643 | - |
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)